SHELTON, CONNECTICUT / ACCESS Newswire / October 29, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), announced that Nanoviricides CEO Dr Anil Diwan joined ...

Synthetic biology is ready for the next developmental milestone and America’s leadership depends on getting the financing right.

Once a niche asset class serving grocers and food processors, cold storage has evolved into one of the most dynamic, data-driven, and capital-intensive property types in commercial real estate.

Over the past few decades, the Triangle’s life sciences sector has been a monolithic growth engine, but now it’s bifurcated.

Alnylam Pharmaceuticals, Inc. is rated Hold due to high expectations, competitive threats, and revenue expansion. Learn more ...

The US Health Resources and Services Administration (HRSA) revealed the initial nine drugs to be included in the 340B rebate ...

But Doustdar also seems to recognize what he has in Novo Nordisk, the 100-year-old pharma that brought insulin to the masses, ...

Chip Frazier, a retired United States Air Force officer, is running a campaign to secure one of two seats open on Oak Island’s town council. Though the council race is ...

The move, announced Thursday, escalates the competition between the two pharmaceutical giants for a critical advantage in the ...

As global supply chains evolve amid shifting economic landscapes and growing demand across Asia, Singapore’s Changi Airport stands as a beacon of innovation and resilience in air cargo. In 2024, ...

Shares in Mayne Pharma plunged by nearly a third on Friday after it emerged that Australia's treasurer was considering blocking a A$672 million ($435 million) offer for the company from now-reluctant ...